Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DFNA5 Antikörper (N-Term)

DFNA5 Reaktivität: Human WB, IHC (p), FACS Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5531009
  • Target Alle DFNA5 Antikörper anzeigen
    DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
    Bindungsspezifität
    • 15
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 59-87, N-Term
    Reaktivität
    • 25
    • 20
    • 18
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 37
    • 3
    Kaninchen
    Klonalität
    • 37
    • 3
    Polyklonal
    Konjugat
    • 20
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser DFNA5 Antikörper ist unkonjugiert
    Applikation
    • 35
    • 18
    • 13
    • 13
    • 11
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
    Aufreinigung
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
    Immunogen
    This DFNA5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59-87 amino acids from the N-terminal region of human DFNA5.
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product DFNA5 Primärantikörper
  • Applikationshinweise
    For WB starting dilution is: 1:1000

    For IHC-P starting dilution is: 1:50~100

    For FACS starting dilution is: 1:10~50
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    2 mg/mL
    Buffer
    Supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Target
    DFNA5 (Deafness, Autosomal Dominant 5 (DFNA5))
    Andere Bezeichnung
    DFNA5 (DFNA5 Produkte)
    Hintergrund
    Hearing impairment is a heterogeneous condition with over 40 loci described. DFNA5 is expressed in fetal cochlea, however, its function is not known.
    Molekulargewicht
    55 kDa
    Gen-ID
    1687
    UniProt
    O60443
    Pathways
    Sensory Perception of Sound
Sie sind hier:
Kundenservice